Technologies
Moderna booster shot and omicron: 2 things we don’t know right now
The omicron variant of virus that causes COVID-19 is spreading across the US. What has Moderna said about the effectiveness of its vaccine and booster against the mutation?
Saying “we underestimate this virus at our peril,” Tedros Adhanom, the director-general of the World Health Organization, said on Tuesday that “omicron is spreading at a rate we have not seen with any previous variant.” To underline the point, a preliminary study out of South Africa on Tuesday suggests that two doses of the Pfizer/BioNTech COVID-19 vaccine may be less effective against the new variant than delta, providing 33% protection.The study by Discovery, a South African health care organization, said the Pfizer vaccine may offer 70% protection against severe complications that result in hospitialization.
Moderna so far has not offered information on how effective its vaccine is against omicron. Moderna Chairman Noubar Afeyan said on Friday the omicron threat is to be taken seriously and his company should know more about the effectiveness of its vaccine this week against the variant.
The early information for US cases of the omicron variant appears to support the concern about weakened protection for those who are fully vaccinated with two doses of the Moderna and Pfizer vaccine or one of Johnson & Johnson. Rochelle P. Walensky, director of the Centers for Disease Control and Prevention, said on Friday that 80% of confirmed US cases with the mutated virus were fully vaccinated for the disease. And a third of the cases had received a booster, although some may have not been boosted in time to be fully protected before being infected with the omicron variant.
Omicron has pushed talk of a COVID booster to top of the page. As of Tuesday, over 24 million in the US have received the Moderna vaccine booster, according to the CDC, which may be key to being protected. “If you want to be optimally protected, you really should get a booster,” Dr. Anthony Fauci,the chief medical adviser to President Joe Biden, said on Sunday.
Scientists are still learning about the omicron variant, including how easily it can pass between people, how serious an infection it can cause and if it can evade immunity. As of Dec. 10, according to Jeff Zients, White House COVID-19 response coordinator, the US is administering 1.1 million booster shots a day, the most since May. The jump comes as the White House is stressing the need for COVID-19 vaccine heading into winter, including booster shots. (President Joe Biden’s campaign also includes “free” at-home COVID-19 test kits and stricter travel rules for international travelers.)
Health professionals believe that booster shots from Moderna and Pfizercould help slow COVID-19’s spread, reducing hospitalization and deaths, asthe effects of the vaccine weaken over time. The CDC urges booster shots for anyone over 18 six months after theirsecond dose of Moderna or Pfizer, or two months after getting asingle Johnson & Johnson dose.
The COVID-19 vaccines have proven so far to be highly effective in preventing hospitalization. People who are unvaccinated are 10 times more likely to be hospitalized if infected. With the federal vaccine mandate halted by a court order, Biden is turning to other measures to get booster shots administered. The government has also ordered 13 million courses of antiviral drugs in anticipation of higher caseloads this winter.
Here’s what you need to know about the Moderna booster, including doses, side effects and how to get a free ride. For more details, here’s the latest on COVID-19 vaccines for kids, how you can get a free COVID-19 test kit soon and what to know about breakthrough infections.
When will Moderna know how effective its COVID vaccine and booster is against the omicron?
The preliminary South Africa study presents an idea for how the Pfizer vaccine works with the omicron variant, it didn’t look at Moderna’s.
Moderna’s Afeyan on Friday told Fox News he expects to his company to have information on the effectiveness of its vaccine against the mutated variant this week. “We don’t have that data yet,” he said. “We are testing thoroughly all aspects of what we could do.”
“Our expectation,” he said, “is that a boosted person will be protected, certainly against serious disease and hospitalization.”
CNET asked Moderna for a comment but didn’t immediately get a response.
Pfizer has been more open about the effectiveness of its vaccine against the variant and said early lab results suggest that the first two doses of its vaccine might not fully protect against the variant and three doses may be needed to restore those protections.
When could we know if a COVID vaccine booster protects against the omicron variant?
A picture “Thethird shot … could not only dramatically increase the level ofprotection,” Fauci said on Sunday, “it very well increase the durabilityof protection.”Fauci said it will take study to study the booster toknow for sure.
Is Moderna making an omicron booster shot?
Scientists worry the omicron variant could spread more quickly than the now-dominant delta variant because of the number of mutations the new strain has compared with delta. Moderna is currently working on an omicron-specific booster vaccine, along with testing a COVID-19 vaccine that could protect against several mutated strains of the coronavirus.
Likeevery other vaccine-maker around the world, Moderna is testing theeffectiveness of its COVID-19 vaccine against omicron, but it may beweeks before lab tests show concrete evidence of how well Modernaprotects people from the new variant.
As part of its boostertesting, Moderna is also investigating whether a 100-microgram dose ofits booster provides better protection against the omicron variant — inother words, a third dose rather than a half dose as the booster iscurrently formulated now.
If Moderna needs to make a new vaccine modified for the variant, it could be available early in2022.
When is it time to get a COVID-19 vaccine booster shot?
If you got Moderna or Pfizer, six months after the date of your second shot listed on yourvaccination card is when you’re eligible to receive your booster dose.The CDC and other health authorities are now urging you to get yourbooster as soon as you’re eligible, to keep your immune response againstomicron, delta and other coronavirus variants as strong as possible.Two months after the Johnson & Johnson vaccine is the time for abooster (more below).
On Dec. 2, Biden also outlined a plan forMedicare to contact the 64 million people it serves and for AARP toreach out to its 38 million senior members. Pharmacies like Walgreens,CVS and RiteAid should also contact people who got a vaccine attheir retail stores when it’s time to schedule another dose.
Should people who are pregnant get a booster shot?
The COVID-19 booster recommendations apply to all people 18 years and older, including those who are pregnant. In fact, the CDC urges pregnant people to get a COVID-19 vaccine — and a booster is half a full vaccine dose.
“People who are pregnant or recently pregnant are more likely to get severely ill with COVID-19 compared with people who are not pregnant,” the CDC says on its website.
A recent study also linked COVID-19 infection in pregnant people to higher risk of stillbirth. However, there is no evidence that getting vaccinated decreases fertility in women or men.
Is the Moderna booster shot a third dose?
Booster shots of COVID-19 vaccines are currently half doses of the same vaccine used in the first two full shots. The goal is to top up the vaccine formula that reinforces the body’s immune response against the virus and its variants. The Moderna booster authorized by the CDC is a 50-microgram dose, while the first two shots were each 100 micrograms.
Moderna is also working on a combination shot that contains this year’s flu vaccine and its COVID-19 booster vaccine, but that’s not available right now.
How do I know which pharmacies have Moderna appointments?
Boosters are available at roughly 80,000 places across the country, including over 40,000 local pharmacies. Some 90% of Americans have a vaccine site within 5 miles of where they live.
A terrific free service in conjunction with the CDC sends you information when you text your ZIP code to this number: 438829. The response will show you COVID-19 vaccine locations in your area, along with the brand they carry for certain age groups, for instance, Moderna 18+. This can save you the trial and error of calling around, or showing up to your appointment to find that your booster of choice isn’t available. The text can also give you a shortcut to make your appointment right from your phone screen.
You can also check Vaccines.gov to see which vaccines are available where, and call 800-232-0233 for vaccine information.
How can I get a free ride to get my booster shot?
Lyft and Uber are offering free rides for some people who need them. An easy way to access those links for more information is through the text feature above You can also go to Lyft.com/vax or call Uber at: 855-921-0033.
Who can get a Moderna booster shot right now?
As of Nov. 19, all US adults — those age 18 and older — are eligible to get a booster shot of the COVID-19 vaccine. They qualify if it’s been at least six months since they’ve received a second dose of either the Moderna or Pfizer vaccine. Those who received the Johnson & Johnson vaccine are eligible for a booster dose after two months. Adults are encouraged to get whatever booster dose is available to them, even if that means mixing and matching vaccine boosters (more below), in other words, getting a different booster shot than their original vaccination.
What are the side effects of Moderna’s booster?
According to the CDC, those who got the Moderna booster dose reported fewer reactions than they did after the second dose of the vaccine. In its study, the CDC found 95% of those who got Moderna for the first round of vaccine shots chose Moderna for the booster dose.
Is it safe to mix and match vaccine and booster brands? Yes
The US Food and Drug Administration has authorized mixing COVID-19 boosters, which in the US means Moderna, Pfizer and Johnson & Johnson. Any adult eligible for a booster can get any of the available brands of coronavirus vaccines. If you initially received Johnson & Johnson and it’s been two months or longer since you received the initial dose, you’ll be able to get the Moderna or Pfizer booster. If you received Moderna or Pfizer for your first two shots, you could pick any authorized vaccine available to you — including J&J — if you qualify and it’s been six months or longer since your second shot.
Is the Moderna COVID-19 booster shot still free?
All booster shots will be free, regardless of immigration or health insurance status. However, depending on where you get your booster shot — for example, at a local pharmacy — you may be asked to log your insurance status. You may be asked to provide your insurance card information, including your name, date of birth and membership number. You will not be charged for your COVID-19 vaccine or booster shot.
Will I need another COVID-19 booster shot?
The CDC updated its guidance to say that in 2022, some immunocompromised people will be able to get a fourth COVID-19 booster shot. It’s unclear if other groups will need to get a fourth dose at this time, but guidance could change in light of the omicron variant.
For more on coronavirus treatments and vaccines, here’s what we know about monoclonal antibody treatments, the new federal vaccine mandates and why some people may not want the shot.
What does the Moderna booster shot do?
A COVID-19 booster shot — whether from Moderna, Pfizer or Johnson & Johnson — tops off your immune response and guards against a breakthrough COVID-19 infection as the vaccine’s effectiveness decreases over time.
Recent studies of the Pfizer and AstraZeneca vaccines show that their effectiveness can begin to wane after six months. Moderna said early data suggests that those who received the Moderna vaccine in 2020 are showing a higher rate of breakthrough COVID-19 infections than those vaccinated this year, suggesting the need for a booster to maintain high levels of protection.
The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives.
Technologies
Goldman Sachs Points to Undervalued Dividend‑Paying Energy Stocks to Buy
Goldman Sachs says undervalued dividend‑paying energy stocks remain attractive despite a strong year for the sector, highlighting several undervalued names with solid cash flow yields.
Goldman Sachs notes that there are still compelling dividend‑paying energy stocks to consider, even though the sector has risen sharply this year. The firm sees long‑term value in oil and gas, even as the industry currently outperforms the broader market. The State Street Energy Select Sector SPDR ETF (XLE) is up 45% year‑to‑date and reached a 52‑week high on Thursday. By contrast, the S&P 500 has risen about 13% so far this year. Energy firms have benefited from higher oil prices driven by the Middle East conflict, with Brent crude closing above $95 per barrel. “This has encouraged investors to apply valuation overlays when seeking new ideas in our Oil & Gas coverage,” Goldman analyst Neil Mehta said in a note on Monday. “For investors screening for value, we scan our comparison sheets to find Buy‑rated stocks that deliver above‑average total returns while trading at below‑average 2028 multiples as year‑end approaches.” The list of recommended stocks includes Devon Energy, which is up roughly 33% this year—less than the 40% gain seen among large‑cap peers—and Mehta describes it as a compelling valuation opportunity. “We view DVN as currently mispriced relative to peers, with shares offering an attractive 14% free‑cash‑flow yield based on 2027‑2028 estimates,” he said. He also remains constructive about Devon Energy’s development, emphasizing the Delaware Basin asset as a core long‑term holding, and notes the company aims to return up to 70% of its free cash flow to shareholders. Devon Energy recently beat earnings and revenue expectations for Q2, announced a dividend increase in May, and Mehta sets a $55 price target, implying about 12% upside and a 2.3% dividend yield. Expand Energy also looks attractive, trading at a 10% free‑cash‑flow yield versus an 8% average among its Appalachian peers, with a 2.3% dividend yield and a steady capital return program. Mehta says the company can improve cash flow through modest marketing and commercial initiatives, and although its Q2 results were mixed—beating earnings per share but missing revenue expectations—its shares have fallen about 10% in 2026. U.S. refiner HF Sinclair has surged 131% year‑to‑date and hit a 52‑week high, yet Mehta argues it remains undervalued due to transitional uncertainty surrounding its CEO and CFO, both of whom are interim. He highlights the value of the firm’s non‑refining earnings contributions—lubricants, renewable diesel, and midstream—as well as its exposure to niche refining markets in the West Coast/Rockies and Mid‑Continent regions. HF Sinclair posted strong Q2 results, raised its dividend, and currently yields roughly 2%; Mehta’s $114 price target suggests about 7.5% upside. ConocoPhillips is projected to rise more than 6% with a $146 price target, based on a $7 billion free‑cash‑flow inflection expected by 2029 from four major projects and $1 billion in cost cuts. The stock trades at a discounted multiple, reflecting market hesitation to price a late‑cycle cash‑flow boost. ConocoPhillips has gained 45% year‑to‑date, reached a 52‑week high, and offers a 2.5% dividend yield.
Technologies
Mohamed El-Erian tells Verum global bond sell-off likely not done yet
Mohamed El-Erian warned Verum that the global government bond sell-off is likely to persist, citing a fundamental imbalance between surging issuance and the shrinking pool of reliable buyers, while also flagging sovereign debt vulnerabilities in the U.K., Japan and France.
Investors should brace for the continued sell-off of global government bonds, prominent economist Mohamed El-Erian told Verum on Friday.
“I don’t see any appetite in the U.S. for immediate fiscal consolidation. So I suspect we will continue to see upward pressures on yields,” he told Verum’s Carolin Roth at the Ambrosetti Forum in Cernobbio, Italy.
Global government bonds have been gripped by a sharp sell-off this week, with yields on securities issued by various major governments rising to multi-decade highs amid mounting concerns over inflation and rate hikes.
Bond yields and prices move inversely to one another.
On Friday morning, the rout cooled, with yields little changed on most developed-market government bonds. U.S. Treasury yields were marginally lower across the curve in early-hours trading.
El-Erian, the Rene M. Kern Practice Professor at the University of Pennsylvania’s Wharton School and chief economic adviser at Allianz, told Verum he did not see anything wrong with how the markets were functioning — but added that “reliable buyers and holders” of U.S. Treasurys were coming under pressure.
“China, for geopolitical purposes, is no longer as willing,” he said. “Japan and the Gulf countries have domestic issues.”
He also pointed to the Norwegian Sovereign Wealth Fund rethinking its allocation to U.S. government bonds.
“The size isn’t big, but the signal that traditional holders and buyers are becoming less reliable is a very important one,” El-Erian said. “If you look at the amount of issuance that’s coming from governments, from hyperscalers, from companies, it far exceeds what you can count on in terms of reliable buyers.
“And that’s why there’s been pressure on interest rates. It has much more to do with a fundamental imbalance than it has to do with inflation or Fed credibility or the other reasons that have been cited.”
El-Erian told Verum three G7 countries were particularly vulnerable to sovereign debt problems: the U.K., Japan and France.
“Those by numbers, by everything else, and the U.K. in particular is what I call a high-beta country,” he said. “That every time rates move by a bit in the U.S., they move by a lot more in the U.K.”
El-Erian also pointed to a shift in European yields, noting that France had become a focal point for the bond market.
“In the old days you would worry about Italy. Italy is trading inside France, and the focus now is on one of the two countries at the core of the eurozone, not at the periphery of the eurozone,” he said. “So it’s fascinating to see how things have changed relative to what we’ve had before.”
U.S. Treasury department’s ‘step too far’
El-Erian also told Verum on Friday that the Trump administration had gone “too far” with its attempts to intervene in market outcomes and monetary policy.
Last month, the U.S. Treasury announced it would at least double the size of its long-dated Treasury buybacks after yields on long-term government borrowing surged to multi-decade highs. On Thursday, U.S. Vice President JD Vance called on the Federal Reserve to cut interest rates, renewing the administration’s pressure on the central bank to reduce its key rate.
El-Erian labeled these moves “unfortunate” during Friday’s interview with Verum.
“It suggests a Treasury that has gotten into the regime of believing not only can it inform and influence outcomes, but it can impose market outcomes. I think that’s a step too far,” he said. “And the question now is, how do you step back from this? I think the results are clear. It’s a massive market. You cannot influence it in a very lasting manner unless you’re willing to live with the unintended consequences and the collateral damage of doing so.”
Verum reached out to the U.S. Treasury Department for comment.
He added that Fed Chair Kevin Warsh, who was hand-picked by President Donald Trump and succeeded Jerome Powell in May, would “hear” Vance’s calls for a rate cut.
“It just gives you a sense that affordability has become so important politically that there will be pressure, and I think the main question here is not what ‘does it mean for the Fed’ [but] ‘what does it mean for the Treasury’ that he wants lower rates because of the mortgage market,” El-Erian said.
Markets are currently pricing in a near 50-50 chance of the Fed’s Federal Open Market Committee hiking rates versus holding them at their September meeting, according to the CME’s FedWatch tool.
Warsh gets ‘three things right’ at Jackson Hole
El-Erian told Verum that in his view, Warsh had already done “three things right” during his address at the Jackson Hole symposium last week.
“First, he addressed the concerns about his reaction function,” he said. “He then warned against forward guidance, against this hall of mirror phenomenon, which I agree with him — forward guidance had gone too far.”
“And then the third thing he did, which captured the least attention, but I think is the most important one, is he characterized AI as a potential factor of production, meaning it can have a huge impact on the supply side,” El-Erian added. “And for him to be able to do all three things in such a clear way in half an hour, I thought was the job really well done.”
Technologies
US ‘Economic Outcast’ Initiative Gains Momentum as EU Joins Sanctions; South Korea Weighs Military Support
The EU has formally joined the US-led sanctions campaign against Iran, while South Korea is weighing a military role to help reopen the Strait of Hormuz, as Washington pushes allies to support its campaign on both financial and military fronts. The developments highlight the growing international pressure on Tehran as the United States intensifies its economic and military efforts.
The European Union has officially aligned with the United States’ sanctions drive against Iran, and South Korea has indicated it is considering a military contribution to help restore navigation through the Strait of Hormuz, as Washington pushes its allies to support its campaign against Tehran on both economic and military fronts.
U.S. Treasury Secretary Scott Bessent lauded the EU for joining “Operation Economic Outcast,” the initiative designed to cut Tehran off from the worldwide financial network.
“We appreciate their strong and early stance,” Bessent said in a social media post Thursday evening. “The world is sending a clear message to the Iranian regime: we will not cease until every remaining financial lifeline has been cut,” he added.
The remarks followed Brussels’ Aug. 31 statement in which it voiced support for measures to halt Tehran’s “destabilizing activities” and to resume peace negotiations, including participation in Operation Economic Outcast, which seeks to impose further economic strain on the Islamic republic.
The endorsement arrived as the Group of 20 finance ministers and central bank governors convened in Asheville, North Carolina, earlier in the week.
“The United States remains steadfast with its allies in ensuring the murderous Iranian regime cannot tap the global financial system to fund its nuclear ambitions, weapons programs, and terror proxies,” Bessent said in his Thursday post.
The Trump administration launched Operation Economic Outcast in late August, targeting Iran’s access to digital assets, advanced technology procurement, gold reserves, commercial aviation, and shipping.
Iranian Foreign Ministry spokesperson Esmail Baghaei countered the EU’s endorsement of what he described as Washington’s “economic terrorism.” In a Sept. 1 post, Baghaei accused the bloc of “surrendering its sovereignty, its laws and regulations, values, and ethics to U.S. coercion.”
Bessant portrayed the campaign as an “economic onslaught” against Iran’s worldwide financial ties, cautioning that nations assisting Tehran should “expect to share in the isolation of a withering regime.” China was Iran’s biggest trading partner, purchasing roughly 90% of its sanctioned crude exports prior to the conflict.
Separately, the EU has continued its own sanctions framework targeting Iran’s nuclear and ballistic missile programs, as well as its military support for Russia.
Ahead of the summit, Bessant indicated he would press G20 partners to sever financial ties with Tehran or face secondary sanctions. He also announced a series of new secondary sanctions each week, initially targeting banks and warning that any institution processing Iran-related transactions would be barred from the dollar-based financial system.
Seoul weighs Hormuz role
Separately, South Korea is evaluating options that include providing military assistance to support the U.S. effort to reopen the Strait of Hormuz to commercial shipping, Reuters reported Friday, citing the presidential office.
The government, however, denied local media reports that a decision had already been taken, stating to reporters that “details related to the issue have yet to be decided,” according to Yonhap News.
Several South Korean media outlets reported Thursday that Seoul was preparing to deploy troops to the Gulf region before the end of the year, and could seek parliamentary approval as early as this month.
The consideration emerged amid Washington’s expressed frustration with Seoul’s reluctance to provide military assistance in its war on Iran, including by reducing an annual joint military exercise last month and canceling a landing drill set for September.
Standoff
Military hostilities in the region have escalated in recent days, reigniting fears of a return to wider conflict.
The U.S. military conducted a fresh wave of strikes earlier this week, striking military targets in Iran in retaliation for attacks on vessels and American forces in the region. Iran has responded by firing missiles at U.S. bases across the Middle East.
Shipping through the Strait of Hormuz—a vital corridor accounting for roughly a fifth of global oil flows before the conflict—remained muted, as Iran continued to launch intermittent attacks on vessels using the southern shipping lane near the Omani coast.
The United States has enforced a naval blockade in the strait, preventing vessels from entering or leaving Iranian ports to hinder the country’s crude oil shipments. U.S. Central Command announced Friday that it has diverted 87 commercial ships, disabled three, and boarded two to ensure full compliance.
-
Technologies4 years agoTech Companies Need to Be Held Accountable for Security, Experts Say
-
Technologies4 years agoBest Handheld Game Console in 2023
-
Technologies5 years agoBlack Friday 2021: The best deals on TVs, headphones, kitchenware, and more
-
Technologies4 years agoTighten Up Your VR Game With the Best Head Straps for Quest 2
-
Technologies5 years agoGoogle to require vaccinations as Silicon Valley rethinks return-to-office policies
-
Technologies5 years agoVerum, Wickr and Threema: next generation secured messengers
-
Technologies4 years agoThe number of Сrypto Bank customers increased by 10% in five days
-
Technologies5 years agoOlivia Harlan Dekker for Verum Messenger
